Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage

Jennifer Jaffe, Lora Alkhawam, Hongyan Du, Kristen Tobin, Judith O'Leary, Glen Pollock, H. Hunt Batjer, Issam A. Awad

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVE: Risk predictors, spectrum of treatment eligibility, and range of expected outcomes have not been validated in consecutive series including all cases of intracerebral hemorrhage (ICH) subjected to a prospective management protocol based on current guidelines. METHODS: Eighty-six cases of ICH were prospectively identified in conjunction with screening for a clinical trial during an 18-month period. All patients were subjected to protocolized management based on published "best practice" guidelines for ICH. Medical records were reviewed by trained researchers, and outcomes were assessed at various time points including latest follow-up (range, 0-24 months; mean, 3.97 months). Initial assessment parameters, treatment eligibility, and outcomes were based on standardized criteria. RESULTS: In accordance with past literature, mortality and functional outcomes were significantly worse in older patients, those with a larger ICH volume, and worse Glasgow Coma Scale scores, in univariate and multivariate models. The presence and severity of associated intraventricular hemorrhage also correlated with mortality and outcome. Significantly lower mortality (P = 0.024) and better functional outcomes (P = 0.018) were achieved at 30 days in patients with an ICH volume of less than 30 cm3 in this series than in previously published community-based historical controls without protocolized care. A tight correspondence between treatment eligibility and treatment administered was found. CONCLUSION: Previous estimates of poorer outcome in patients with ICH might not apply to contemporary management protocols, especially in patients with a smaller ICH volume. Outcome ranges in various risk categories and modeling of treatment eligibility will help project more realistic prognostication and assist with the design of future trials.

Original languageEnglish (US)
Pages (from-to)436-445
Number of pages10
JournalNeurosurgery
Volume64
Issue number3
DOIs
StatePublished - Mar 2009

Fingerprint

Cerebral Hemorrhage
Practice Guidelines
Therapeutics
Mortality
Glasgow Coma Scale
Medical Records
Research Personnel
Clinical Trials
Guidelines
Hemorrhage

Keywords

  • Intracerebral hemorrhage
  • Outcome prediction
  • Treatment

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. / Jaffe, Jennifer; Alkhawam, Lora; Du, Hongyan; Tobin, Kristen; O'Leary, Judith; Pollock, Glen; Batjer, H. Hunt; Awad, Issam A.

In: Neurosurgery, Vol. 64, No. 3, 03.2009, p. 436-445.

Research output: Contribution to journalArticle

Jaffe, Jennifer ; Alkhawam, Lora ; Du, Hongyan ; Tobin, Kristen ; O'Leary, Judith ; Pollock, Glen ; Batjer, H. Hunt ; Awad, Issam A. / Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage. In: Neurosurgery. 2009 ; Vol. 64, No. 3. pp. 436-445.
@article{e8a77aed005d4f8aae52af3d0185d2b3,
title = "Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage",
abstract = "OBJECTIVE: Risk predictors, spectrum of treatment eligibility, and range of expected outcomes have not been validated in consecutive series including all cases of intracerebral hemorrhage (ICH) subjected to a prospective management protocol based on current guidelines. METHODS: Eighty-six cases of ICH were prospectively identified in conjunction with screening for a clinical trial during an 18-month period. All patients were subjected to protocolized management based on published {"}best practice{"} guidelines for ICH. Medical records were reviewed by trained researchers, and outcomes were assessed at various time points including latest follow-up (range, 0-24 months; mean, 3.97 months). Initial assessment parameters, treatment eligibility, and outcomes were based on standardized criteria. RESULTS: In accordance with past literature, mortality and functional outcomes were significantly worse in older patients, those with a larger ICH volume, and worse Glasgow Coma Scale scores, in univariate and multivariate models. The presence and severity of associated intraventricular hemorrhage also correlated with mortality and outcome. Significantly lower mortality (P = 0.024) and better functional outcomes (P = 0.018) were achieved at 30 days in patients with an ICH volume of less than 30 cm3 in this series than in previously published community-based historical controls without protocolized care. A tight correspondence between treatment eligibility and treatment administered was found. CONCLUSION: Previous estimates of poorer outcome in patients with ICH might not apply to contemporary management protocols, especially in patients with a smaller ICH volume. Outcome ranges in various risk categories and modeling of treatment eligibility will help project more realistic prognostication and assist with the design of future trials.",
keywords = "Intracerebral hemorrhage, Outcome prediction, Treatment",
author = "Jennifer Jaffe and Lora Alkhawam and Hongyan Du and Kristen Tobin and Judith O'Leary and Glen Pollock and Batjer, {H. Hunt} and Awad, {Issam A.}",
year = "2009",
month = "3",
doi = "10.1227/01.NEU.0000330402.20883.1B",
language = "English (US)",
volume = "64",
pages = "436--445",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Outcome predictors and spectrum of treatment eligibility with prospective protocolized management of intracerebral hemorrhage

AU - Jaffe, Jennifer

AU - Alkhawam, Lora

AU - Du, Hongyan

AU - Tobin, Kristen

AU - O'Leary, Judith

AU - Pollock, Glen

AU - Batjer, H. Hunt

AU - Awad, Issam A.

PY - 2009/3

Y1 - 2009/3

N2 - OBJECTIVE: Risk predictors, spectrum of treatment eligibility, and range of expected outcomes have not been validated in consecutive series including all cases of intracerebral hemorrhage (ICH) subjected to a prospective management protocol based on current guidelines. METHODS: Eighty-six cases of ICH were prospectively identified in conjunction with screening for a clinical trial during an 18-month period. All patients were subjected to protocolized management based on published "best practice" guidelines for ICH. Medical records were reviewed by trained researchers, and outcomes were assessed at various time points including latest follow-up (range, 0-24 months; mean, 3.97 months). Initial assessment parameters, treatment eligibility, and outcomes were based on standardized criteria. RESULTS: In accordance with past literature, mortality and functional outcomes were significantly worse in older patients, those with a larger ICH volume, and worse Glasgow Coma Scale scores, in univariate and multivariate models. The presence and severity of associated intraventricular hemorrhage also correlated with mortality and outcome. Significantly lower mortality (P = 0.024) and better functional outcomes (P = 0.018) were achieved at 30 days in patients with an ICH volume of less than 30 cm3 in this series than in previously published community-based historical controls without protocolized care. A tight correspondence between treatment eligibility and treatment administered was found. CONCLUSION: Previous estimates of poorer outcome in patients with ICH might not apply to contemporary management protocols, especially in patients with a smaller ICH volume. Outcome ranges in various risk categories and modeling of treatment eligibility will help project more realistic prognostication and assist with the design of future trials.

AB - OBJECTIVE: Risk predictors, spectrum of treatment eligibility, and range of expected outcomes have not been validated in consecutive series including all cases of intracerebral hemorrhage (ICH) subjected to a prospective management protocol based on current guidelines. METHODS: Eighty-six cases of ICH were prospectively identified in conjunction with screening for a clinical trial during an 18-month period. All patients were subjected to protocolized management based on published "best practice" guidelines for ICH. Medical records were reviewed by trained researchers, and outcomes were assessed at various time points including latest follow-up (range, 0-24 months; mean, 3.97 months). Initial assessment parameters, treatment eligibility, and outcomes were based on standardized criteria. RESULTS: In accordance with past literature, mortality and functional outcomes were significantly worse in older patients, those with a larger ICH volume, and worse Glasgow Coma Scale scores, in univariate and multivariate models. The presence and severity of associated intraventricular hemorrhage also correlated with mortality and outcome. Significantly lower mortality (P = 0.024) and better functional outcomes (P = 0.018) were achieved at 30 days in patients with an ICH volume of less than 30 cm3 in this series than in previously published community-based historical controls without protocolized care. A tight correspondence between treatment eligibility and treatment administered was found. CONCLUSION: Previous estimates of poorer outcome in patients with ICH might not apply to contemporary management protocols, especially in patients with a smaller ICH volume. Outcome ranges in various risk categories and modeling of treatment eligibility will help project more realistic prognostication and assist with the design of future trials.

KW - Intracerebral hemorrhage

KW - Outcome prediction

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=62849118276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62849118276&partnerID=8YFLogxK

U2 - 10.1227/01.NEU.0000330402.20883.1B

DO - 10.1227/01.NEU.0000330402.20883.1B

M3 - Article

C2 - 19240605

AN - SCOPUS:62849118276

VL - 64

SP - 436

EP - 445

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 3

ER -